On Oct 25, Eurobo Pharmaceuticals Appointed Marshall H. Woodworth As Co's Acting CFO, Principal Financial Officer And Principal Accounting Officer

NEUROBO PHARMACEUTICALS INC -1.20% Post

NEUROBO PHARMACEUTICALS INC

NRBO

5.75

5.75

-1.20%

0.00% Post

- SEC Filing

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via